Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.

MLA

Barbin, Laetitia, et al. “Comparative Efficacy of Fingolimod vs Natalizumab: A French Multicenter Observational Study.” Neurology, vol. 86, no. 8, Feb. 2016, pp. 771–78. EBSCOhost, https://doi.org/10.1212/WNL.0000000000002395.

APA

Barbin, L., Rousseau, C., Jousset, N., Casey, R., Debouverie, M., Vukusic, S., De Sèze, J., Brassat, D., Wiertlewski, S., Brochet, B., Pelletier, J., Vermersch, P., Edan, G., Lebrun-Frenay, C., Clavelou, P., Thouvenot, E., Camdessanché, J.-P., Tourbah, A., Stankoff, B., … Laplaud, D. A. (2016). Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study. Neurology, 86(8), 771–778. https://doi.org/10.1212/WNL.0000000000002395

Chicago

Barbin, Laetitia, Chloe Rousseau, Natacha Jousset, Romain Casey, Marc Debouverie, Sandra Vukusic, Jerome De Sèze, et al. 2016. “Comparative Efficacy of Fingolimod vs Natalizumab: A French Multicenter Observational Study.” Neurology 86 (8): 771–78. doi:10.1212/WNL.0000000000002395.